Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid
- PMID: 3258308
Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid
Abstract
In this study, A2780 human ovarian carcinoma cells were grown in folinic acid in contrast to folic acid, and the molecular and biochemical properties of cisplatin-resistant A2780 cells were analyzed for changes in the dTMP synthase cycle. At concentrations of folinic acid that were optimal for cell growth (10(-8) M), the ED50 for cisplatin was 2.5 and 43 microM in the A2780S and A2780DDP cells, respectively. Resistance to cisplatin was associated with a 2-fold cross-resistance to 5-fluorodeoxyuridine and 5-fluorouracil as well as a 3-fold increase in both dTMP synthase activity and mRNA. The ED50 for methotrexate was similar in both A2780S and A2780DDP cells (1.2 microM). When both the A2780S and A2780DDP cells were grown in folinic acid, there was no significant difference in the level of dihydrofolate reductase activity. This data would suggest that cisplatin resistance is associated with changes in folate metabolism.
Similar articles
-
Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.Proc Natl Acad Sci U S A. 1988 Feb;85(3):650-3. doi: 10.1073/pnas.85.3.650. Proc Natl Acad Sci U S A. 1988. PMID: 3422447 Free PMC article.
-
Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells.J Biol Chem. 1990 Jul 5;265(19):11285-8. J Biol Chem. 1990. PMID: 2113532
-
Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.Eur J Pharmacol. 2009 Aug 1;615(1-3):17-26. doi: 10.1016/j.ejphar.2009.04.062. Epub 2009 May 14. Eur J Pharmacol. 2009. PMID: 19446547
-
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.Biochim Biophys Acta. 2002 Jul 18;1587(2-3):194-205. doi: 10.1016/s0925-4439(02)00082-0. Biochim Biophys Acta. 2002. PMID: 12084461 Review.
-
Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.Biochim Biophys Acta. 2002 Jul 18;1587(2-3):164-73. doi: 10.1016/s0925-4439(02)00079-0. Biochim Biophys Acta. 2002. PMID: 12084458 Review.
Cited by
-
Relationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.Br J Cancer. 1997;76(1):77-82. doi: 10.1038/bjc.1997.339. Br J Cancer. 1997. PMID: 9218736 Free PMC article.
-
Dual-Targeted Zeolitic Imidazolate Frameworks Drug Delivery System Reversing Cisplatin Resistance to Treat Resistant Ovarian Cancer.Int J Nanomedicine. 2024 Jul 3;19:6603-6618. doi: 10.2147/IJN.S434950. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38979533 Free PMC article.
-
E3 ubiquitin ligase HOIP attenuates apoptotic cell death induced by cisplatin.Cancer Res. 2014 Apr 15;74(8):2246-2257. doi: 10.1158/0008-5472.CAN-13-2131. Epub 2014 Mar 31. Cancer Res. 2014. PMID: 24686174 Free PMC article.
-
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.Br J Cancer. 1999 Jun;80(7):981-90. doi: 10.1038/sj.bjc.6690452. Br J Cancer. 1999. PMID: 10362105 Free PMC article.
-
Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer.Cancer Chemother Pharmacol. 2018 Jul;82(1):39-48. doi: 10.1007/s00280-018-3588-6. Epub 2018 Apr 25. Cancer Chemother Pharmacol. 2018. PMID: 29696360 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources